Each protein dose can trigger a fresh GLP-1 response
Focus on compound movements that recruit multiple muscle groups and allow you to handle meaningful weight
1 Patients taking semaglutide will lose an average of 3.8 to 4.7 kg (8.4 to 10.4 lb)
Our options include: GLP-1 Therapy Encourages appetite regulation and improved insulin control GIP Peptide Therapy Enhances metabolic efficiency and energy balance Micro-Dosing Protocols Subtle, longevity-focused support for metabolic and hormonal health Every plan is compounded and monitored under medical supervision to ensure safety, precision, and personalized progress
Products can differ in size, shape, color, and markings from country to country
Collagen peptides, in association with vitamin C, sodium hyaluronate, manganese and copper, as part of the rehabilitation project in the treatment of chronic low back pain